BSECompany Update3 Nov 2026 · 3 Nov 2026, 06:09 pm
Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the Quarter and Half year ended September 30, 2026 and Any other business with the permission of the chair
Vivanza Biosciences Ltd · 530057
✦ AI SummaryResults
Vivanza Biosciences Ltd has postponed and rescheduled its Board meeting to discuss unaudited financial results for the quarter and half year ended September 30, 2026, due to unavoidable circumstances.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Vivanza Biosciences Ltd - 530057 - Board Meeting Intimation for Postponement And Rescheduling Of Board Meeting Pursuant To Regulation 29 & 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Attachments (1)
📄pdf
Download →
cf905575-a106-4fa3-9967-20336b115cd9.pdf
View document text
VIVANZA BIOSCIENCES LIMITED
Regd. Office: 403, Sarthik 2, Opp. Rajpath Club, S. G. Highway, Ahmedabad 380054.
Phone: 079-26870953, email: info@vivanzabiosciences.com, website: www.vivanzabiosciences.com
CIN: L24105GJ1982PLC005057
Date: 03rd November,2026
Department of Corporate Services,
BSE Limited,
Ground Floor, P. J. Towers,
Dalal Street,
Mumbai – 400001,
Scrip Code: 530057 ISIN: INE984E01035
Subject: Intimation regarding Postponement and Rescheduling of Board Meeting pursuant to
Regulation 29 & 30 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015
Dear Sir/Madam,
With reference to the above-captioned subject and pursuant to Regulation 29 and 30 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of
the Board of Directors of the Company, which was earlier scheduled to be held on Tuesday, November
03rd, 2026, at 03:30 P.M has been postponed and rescheduled due to unavoidable circumstances to
Friday, 06th November, 2026 at 03:30 P.M. at the registered office of the Company situated at 403,
Sarthik 2, Opp. Rajpath Club, S. G. Highway, Ahmedabad 380054 to discuss and consider, inter-alia:
1. Unaudited Standalone and Consolidated Financial Results along with Limited Review Report of
the Company for the Quarter and Half year ended September 30, 2026;
2. Any other business with the permission of the chair;
As per Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,
Intimation of the Board meeting would be made available on the website of the company at:
https://vivanzabiosciences.com/announcement/
Further, as already informed, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 as
amended from time to time, and Company's Internal Code for Prohibition of Insider Trading ('Code'), the
trading window for dealing in the securities of the Company for the Directors/Officers & Key Managerial
Personnel and Designated Persons of the Company defined under the Code has already been closed till
the expiry of 48 hours after the declaration of Unaudited Financial Results for the Quarter and Half year
ended 30th September, 2026.
We request you to take the same on record.
Thanking you
For Vivanza Biosciences Limited
JAYENDRA MEHTA
MANAGING DIRECTOR
DIN: 08210602